In ZINC since | Heavy atoms | Benign functionality |
---|---|---|
October 5th, 2005 | 17 | Yes |
Popular Name: Resveratrol Resveratrol
Find On: PubMed — Wikipedia — Google
CAS Numbers: 1089051-56-8 , 204076-78-8; 36469-58-6; 501-36-0 , 501-36-0
(E)-5-(2-(4-hydroxyphenyl)ethenyl)-1,3-benzenediol
(E)-5-(4-Hydroxystyryl)benzene-1,3-diol
(E)-5-(p-Hydroxystyryl)resorcinol
(E)-5-[2-(4-hydroxyphenyl)ethenyl]-1,3-benzendiol
(E)-5-[2-(4-Hydroxyphenyl)ethenyl]-1,3-benzenediol
1,3-Benzenediol, 5-(2-(4-hydroxyphenyl)ethenyl)-, (E)-
1,3-benzenediol, 5-[(E)-2-(4-hydroxyphenyl)ethenyl]-
3,4',5-Trihydroxy-trans-stilbene
3,4',5-trihydroxystilbene; 3,5,4'-trihydroxystilbene; 501-36-0; CPD-83; resveratrol
3,4',5-Trihydroxystilbene; 501-36-0; C03582; Resveratrol; trans-Resveratrol
3,4',5-Trihydroxystilbene;trans-3,4',5 - Trihydroxystilbene;trans-Resveratrol
3,4_,5-Trihydroxy-trans-stilbene
3,5,4'-Trihydroxy-trans-stilbene
5-((1E)-2-(4-Hydroxyphenyl)ethenyl)-1,3-benzenediol
5-[(1E)-2-(4-Hydroxyphenyl)ethenyl]-1,3-benzenediol
5-[(E)-2-(4-hydroxyphenyl)ethenyl]benzene-1,3-diol
5-[(E)-2-(4-hydroxyphenyl)vinyl]benzene-1,3-diol
5-[2-(4-hydroxyphenyl)ethenyl]benzene-1,3-diol
5-[2-(4-hydroxyphenyl)vinyl]-1,3-benzenediol
501-36-0; Prestwick_619; Resveratrol
533C1DA0-4104-42B5-9D32-9265F40857E4
CHEBI:1366; CHEBI:19867; CHEBI:11685
CPD000058206; Resveratrol; 501-36-0
CPD000058206; RESVERATROL; SAM001246888
InChI=1/C14H12O3/c15-12-5-3-10(4-6-12)1-2-11-7-13(16)9-14(17)8-11/h1-9,15-17H/b2-1
InChI=1/C14H12O3/c15-12-5-3-10(4-6-12)1-2-11-7-13(16)9-14(17)8-11/h1-9,15-17H/b2-1+
Resveratrol [501-36-0]; (trans-3,5,4'-Stilbenetriol)
trans-1,2-(3,4',5-Trihydroxydiphenyl)ethylene
Type pH range | xlogP | Des A‑Pol Apolar desolvation (kcal/mol) | Des Pol Polar desolvation (kcal/mol) | H Don H-bond donors | H Acc H-bond acceptors | Chg Net charge | tPSA (Ų) | MWT Molecular weight (g/mol) | RB Rotatable bonds | DL |
---|---|---|---|---|---|---|---|---|---|---|
Ref Reference (pH 7) | 2.99 | 0.79 | -8.46 | 3 | 3 | 0 | 61 | 228.247 | 2 | ↓ |
Note Type | Comments | Provided By |
---|---|---|
MP | 253 - 255 °C | Fluorochem |
MP | 253-255o C | Indofine |
MP | 253-255°C | Indofine |
MP | 254° | Matrix Scientific |
Mp [°C] | 261 - 263 | Acros Organics |
MP | 263-265° | Oakwood Chemical |
UniProt Database Links | 4CL1_ARATH; 4CL1_DICDI; 4CL1_ORYSJ; 4CL1_PETCR; 4CL1_SOLTU; 4CL1_SOYBN; 4CL1_TOBAC; 4CL2_ARATH; 4CL2_DICDI; 4CL2_ORYSJ; 4CL2_PETCR; 4CL2_SOLTU; 4CL2_SOYBN; 4CL2_TOBAC; 4CL3_ARATH; 4CL3_DICDI; 4CL3_ORYSJ; 4CL4_ARATH; 4CL4_ORYSJ; 4CL5_ORYSJ; 4CL_PINTA; 4CL_ | ChEBI |
Purity | 50-97% | APIChem |
ALOGPS_SOLUBILITY | 6.88e-02 g/l | DrugBank-experimental |
Purity | 95+% | Matrix Scientific |
Purity | >98% | Fluorochem |
Indications | antidiabetic | KeyOrganics Bioactives |
Indications | antidiabetic, obesity, cancer | KeyOrganics Bioactives |
Therapy | antifungal, antibacterial | SMDC Iconix |
Indications | antioxidant, antiviral | KeyOrganics Bioactives |
biological_use | Bactericide | IBScreen Bioactives |
Target | Cellular tumor antigen p53(P04637)&Apoptosis regulator BAX(Q07812)&Apoptotic protease-activating factor 1(O14727)&RAC-alpha serine/threonine-protein kinase(P31749)&Signal transducer and activator of transcription 1-alpha/beta(P42224)&Caspase-3(P42574)&NAD | Herbal Ingredients Targets |
Patent Database Links | EP1574499; EP1669067; EP1676570; EP1726292; EP1762234; EP1779858; EP1825850; EP1837056; EP1844784; EP1852430; EP1872792; EP1897530; EP1911358; EP1925311; EP1932516; EP1932517; EP1952796; EP1982603; EP1982707; EP1992322; GB2362101; US2003199581; US20041163 | ChEBI |
biological_use | Fungicide | IBScreen Bioactives IBScreen Bioactives |
H phrase | H318: Causes serious eye damage | Acros Organics |
H phrase | H318: Causes serious eye damage; H335: May cause respiratory irritation; H315: Causes skin irritation; H317: May cause an allergic skin reaction; H302: Harmful if swallowed | Acros Organics |
Warnings | IRRITANT | Matrix Scientific |
Target | Mediator of DNA damage checkpoint protein 1(Q14676)&Cellular tumor antigen p53(P04637)&Cyclin-dependent kinase inhibitor 1(P38936)&Cell division control protein 2 homolog(P06493)&Apoptosis regulator BAX(Q07812) | Herbal Ingredients Targets |
PUBCHEM_SUBSTANCE_COMMENT | NCC_SAMPLE_SUPPLIER : Sigma Chemical Company; NCC_SUPPLIER_STRUCTURE_ID : R5010 | NIH Clinical Collection via PubChem |
biological_use | Neutriceutical with a positive influence on blood lipid profile | IBScreen Bioactives |
P phrase | P305 + P351 + P338: IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing | Acros Organics |
P phrase | P305 + P351 + P338: IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing; P310: Immediately call a POISON CENTER or doctor/physician; P280: Wear eye protection/face protection; P26 | Acros Organics |
R phrase | R22: Harmful if swallowed. | Acros Organics |
R phrase | R22: Harmful if swallowed.; R37/38: Irritating to respiratory system and skin.; R41: Risk of serious damage to eyes.; R43: May cause sensitisation by skin contact. | Acros Organics |
biological_use | Resveratrol in red wines has been postulated to be associated with beneficial health effects | IBScreen Bioactives |
S phrase | S26: In case of contact with eyes, rinse immediately with plenty of water and seek medical advice. | Acros Organics |
S phrase | S26: In case of contact with eyes, rinse immediately with plenty of water and seek medical advice.; S36/37/39: Wear suitable protective clothing, gloves and eye/face protection. | Acros Organics |
PUBCHEM_SUBSTANCE_COMMENT | SAMPLE_SUPPLIER: Sigma Chemical Company; SUPPLIER_STRUCTURE_ID: R5010 | NIH Clinical Collection via PubChem |
Target | Sirtuin | Selleck Chemicals |
mechanism | Tyrosinase inhibitor | IBScreen Bioactives |
Patent Database Links | US2003069277; US2008268097; WO2005037843; WO2006101761; WO2007098091 | ChEBI |
Hazard | XN: Harmful | Acros Organics |
Code | Description | Organism Class | Affinity (nM) | LE (kcal/mol/atom) | Type |
---|---|---|---|---|---|
AHR-1-E | Aryl Hydrocarbon Receptor (cluster #1 Of 1), Eukaryotic | Eukaryotes | 169 | 0.56 | Binding ≤ 10μM |
CAH1-4-E | Carbonic Anhydrase I (cluster #4 Of 12), Eukaryotic | Eukaryotes | 2210 | 0.47 | Binding ≤ 10μM |
CAH12-2-E | Carbonic Anhydrase XII (cluster #2 Of 9), Eukaryotic | Eukaryotes | 950 | 0.50 | Binding ≤ 10μM |
CAH13-7-E | Carbonic Anhydrase XIII (cluster #7 Of 7), Eukaryotic | Eukaryotes | 4090 | 0.44 | Binding ≤ 10μM |
CAH14-4-E | Carbonic Anhydrase XIV (cluster #4 Of 8), Eukaryotic | Eukaryotes | 830 | 0.50 | Binding ≤ 10μM |
CAH15-1-E | Carbonic Anhydrase 15 (cluster #1 Of 6), Eukaryotic | Eukaryotes | 9360 | 0.41 | Binding ≤ 10μM |
CAH2-5-E | Carbonic Anhydrase II (cluster #5 Of 15), Eukaryotic | Eukaryotes | 2770 | 0.46 | Binding ≤ 10μM |
CAH3-1-E | Carbonic Anhydrase III (cluster #1 Of 6), Eukaryotic | Eukaryotes | 9090 | 0.42 | Binding ≤ 10μM |
CAH4-3-E | Carbonic Anhydrase IV (cluster #3 Of 16), Eukaryotic | Eukaryotes | 4470 | 0.44 | Binding ≤ 10μM |
CAH5A-8-E | Carbonic Anhydrase VA (cluster #8 Of 10), Eukaryotic | Eukaryotes | 4750 | 0.44 | Binding ≤ 10μM |
CAH5B-4-E | Carbonic Anhydrase VB (cluster #4 Of 9), Eukaryotic | Eukaryotes | 4640 | 0.44 | Binding ≤ 10μM |
CAH6-2-E | Carbonic Anhydrase VI (cluster #2 Of 8), Eukaryotic | Eukaryotes | 8070 | 0.42 | Binding ≤ 10μM |
CAH7-2-E | Carbonic Anhydrase VII (cluster #2 Of 8), Eukaryotic | Eukaryotes | 4350 | 0.44 | Binding ≤ 10μM |
CAH9-3-E | Carbonic Anhydrase IX (cluster #3 Of 11), Eukaryotic | Eukaryotes | 810 | 0.50 | Binding ≤ 10μM |
ESR1-5-E | Estrogen Receptor Alpha (cluster #5 Of 5), Eukaryotic | Eukaryotes | 785 | 0.50 | Binding ≤ 10μM |
NQO2-4-E | Quinone Reductase 2 (cluster #4 Of 4), Eukaryotic | Eukaryotes | 960 | 0.50 | Binding ≤ 10μM |
PGH1-2-E | Cyclooxygenase-1 (cluster #2 Of 6), Eukaryotic | Eukaryotes | 830 | 0.50 | Binding ≤ 10μM |
PGH2-1-E | Cyclooxygenase-2 (cluster #1 Of 8), Eukaryotic | Eukaryotes | 3490 | 0.45 | Binding ≤ 10μM |
PGH1-1-E | Cyclooxygenase-1 (cluster #1 Of 2), Eukaryotic | Eukaryotes | 2840 | 0.46 | Functional ≤ 10μM |
Z102306-4-O | Aorta (cluster #4 Of 6), Other | Other | 6918 | 0.42 | Functional ≤ 10μM |
Z80156-1-O | HL-60 (Promyeloblast Leukemia Cells) (cluster #1 Of 12), Other | Other | 5000 | 0.44 | Functional ≤ 10μM |
Z80224-12-O | MCF7 (Breast Carcinoma Cells) (cluster #12 Of 14), Other | Other | 0 | 0.00 | Functional ≤ 10μM |
Z80418-1-O | RAW264.7 (Monocytic-macrophage Leukemia Cells) (cluster #1 Of 9), Other | Other | 4000 | 0.44 | Functional ≤ 10μM |
Z80492-2-O | SK-N-SH (Neuroblastoma Cells) (cluster #2 Of 2), Other | Other | 0 | 0.00 | Functional ≤ 10μM |
Z80682-7-O | A549 (Lung Carcinoma Cells) (cluster #7 Of 11), Other | Other | 0 | 0.00 | Functional ≤ 10μM |
Z81247-2-O | HeLa (Cervical Adenocarcinoma Cells) (cluster #2 Of 9), Other | Other | 0 | 0.00 | Functional ≤ 10μM |
Uniprot | Swissprot | Description | Affinity (nM) | LE (kcal/mol/atom) | Type |
---|---|---|---|---|---|
AHR_RABIT | O02747 | Aryl Hydrocarbon Receptor, Rabit | 169 | 0.56 | Binding ≤ 1μM |
CAH9_HUMAN | Q16790 | Carbonic Anhydrase IX, Human | 810 | 0.50 | Binding ≤ 1μM |
CAH12_HUMAN | O43570 | Carbonic Anhydrase XII, Human | 950 | 0.50 | Binding ≤ 1μM |
CAH14_HUMAN | Q9ULX7 | Carbonic Anhydrase XIV, Human | 830 | 0.50 | Binding ≤ 1μM |
PGH1_HUMAN | P23219 | Cyclooxygenase-1, Human | 830 | 0.50 | Binding ≤ 1μM |
PGH1_SHEEP | P05979 | Cyclooxygenase-1, Sheep | 380 | 0.53 | Binding ≤ 1μM |
PGH2_HUMAN | P35354 | Cyclooxygenase-2, Human | 750 | 0.50 | Binding ≤ 1μM |
ESR1_HUMAN | P03372 | Estrogen Receptor Alpha, Human | 785 | 0.50 | Binding ≤ 1μM |
NQO2_HUMAN | P16083 | Quinone Reductase 2, Human | 450 | 0.52 | Binding ≤ 1μM |
AHR_RABIT | O02747 | Aryl Hydrocarbon Receptor, Rabit | 169 | 0.56 | Binding ≤ 10μM |
CAH15_MOUSE | Q99N23 | Carbonic Anhydrase 15, Mouse | 9360 | 0.41 | Binding ≤ 10μM |
CAH1_HUMAN | P00915 | Carbonic Anhydrase I, Human | 2210 | 0.47 | Binding ≤ 10μM |
CAH2_HUMAN | P00918 | Carbonic Anhydrase II, Human | 2770 | 0.46 | Binding ≤ 10μM |
CAH3_HUMAN | P07451 | Carbonic Anhydrase III, Human | 9090 | 0.42 | Binding ≤ 10μM |
CAH4_HUMAN | P22748 | Carbonic Anhydrase IV, Human | 4470 | 0.44 | Binding ≤ 10μM |
CAH9_HUMAN | Q16790 | Carbonic Anhydrase IX, Human | 810 | 0.50 | Binding ≤ 10μM |
CAH5A_HUMAN | P35218 | Carbonic Anhydrase VA, Human | 4750 | 0.44 | Binding ≤ 10μM |
CAH5B_HUMAN | Q9Y2D0 | Carbonic Anhydrase VB, Human | 4640 | 0.44 | Binding ≤ 10μM |
CAH6_HUMAN | P23280 | Carbonic Anhydrase VI, Human | 8070 | 0.42 | Binding ≤ 10μM |
CAH7_HUMAN | P43166 | Carbonic Anhydrase VII, Human | 4350 | 0.44 | Binding ≤ 10μM |
CAH12_HUMAN | O43570 | Carbonic Anhydrase XII, Human | 950 | 0.50 | Binding ≤ 10μM |
CAH13_HUMAN | Q8N1Q1 | Carbonic Anhydrase XIII, Human | 4090 | 0.44 | Binding ≤ 10μM |
CAH14_HUMAN | Q9ULX7 | Carbonic Anhydrase XIV, Human | 830 | 0.50 | Binding ≤ 10μM |
PGH1_SHEEP | P05979 | Cyclooxygenase-1, Sheep | 2800 | 0.46 | Binding ≤ 10μM |
PGH1_HUMAN | P23219 | Cyclooxygenase-1, Human | 1100 | 0.49 | Binding ≤ 10μM |
PGH2_SHEEP | P79208 | Cyclooxygenase-2, Sheep | 3490 | 0.45 | Binding ≤ 10μM |
PGH2_HUMAN | P35354 | Cyclooxygenase-2, Human | 1300 | 0.48 | Binding ≤ 10μM |
ESR1_HUMAN | P03372 | Estrogen Receptor Alpha, Human | 785 | 0.50 | Binding ≤ 10μM |
NQO2_HUMAN | P16083 | Quinone Reductase 2, Human | 450 | 0.52 | Binding ≤ 10μM |
Z80682 | Z80682 | A549 (Lung Carcinoma Cells) | 0.1 | 0.82 | Functional ≤ 10μM |
Z102306 | Z102306 | Aorta | 6918.30971 | 0.42 | Functional ≤ 10μM |
PGH1_HUMAN | P23219 | Cyclooxygenase-1, Human | 2840 | 0.46 | Functional ≤ 10μM |
Z81247 | Z81247 | HeLa (Cervical Adenocarcinoma Cells) | 0.1 | 0.82 | Functional ≤ 10μM |
Z80156 | Z80156 | HL-60 (Promyeloblast Leukemia Cells) | 5000 | 0.44 | Functional ≤ 10μM |
Z80224 | Z80224 | MCF7 (Breast Carcinoma Cells) | 0.1 | 0.82 | Functional ≤ 10μM |
Z80418 | Z80418 | RAW264.7 (Monocytic-macrophage Leukemia Cells) | 4000 | 0.44 | Functional ≤ 10μM |
Z80492 | Z80492 | SK-N-SH (Neuroblastoma Cells) | 0.1 | 0.82 | Functional ≤ 10μM |
Description | Species |
---|---|
COX reactions | |
Erythrocytes take up carbon dioxide and release oxygen | |
Erythrocytes take up oxygen and release carbon dioxide | |
Nicotinamide salvaging | |
Nuclear Receptor transcription pathway | |
Nuclear signaling by ERBB4 | |
Regulation of gene expression by Hypoxia-inducible Factor | |
Reversible hydration of carbon dioxide | |
Synthesis of 15-eicosatetraenoic acid derivatives | |
Synthesis of Prostaglandins (PG) and Thromboxanes (TX) |